Study of the Safety and Neuroprotective Capacity of Scp776 in Acute Ischemic Stroke
Clinical trial NCT05585606 · COMPLETED
Trial details
- NCT number
- NCT05585606
- Sponsor
- Silver Creek Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-19
- Primary completion
- 2025-09-15
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.